Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Smoking Cessation 11Tobacco Use Disorder 7Smoking 5Lung Neoplasms 5Uterine Cervical Neoplasms 4Tobacco Use Cessation 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Tobacco Use 2Tobacco Smoking 2Small Cell Lung Carcinoma 2Head and Neck Neoplasms 2Cigarette Smoking 2Acquired Immunodeficiency Syndrome 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Substance-Related Disorders 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Overweight 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1

Interventions

Pyridoxine 3Celecoxib 2Capecitabine 2tegafur-gimeracil-oteracil 1mecobalamin 1liposomal doxorubicin 1Vitamin B 6 1Urea 1Tobacco Use Cessation Devices 1Standard of Care 1S 1 (combination) 1Radiotherapy 1Pharmacokinetics 1Medicine, Chinese Traditional 1Low-Level Light Therapy 1Diclofenac 1Cosmetics 1Brimonidine Tartrate 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hand-Foot Syndrome × Tobacco Use Cessation Devices × Clear all
NCT00751101 2020-10-05

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

University of California, San Francisco

Phase 2 Terminated
24 enrolled 12 charts
Breast

Breast Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡